Abstract
This study compared the central effects of ghrelin and leptin on body and bone marrow adiposity and gene expression in adipose tissue and bone marrow. Male Sprague–Dawley rats were injected intracerebroventricular (ICV) twice daily with control, 66 ng ghrelin (G66), 330 ng ghrelin (G330), or 5 μg leptin (L5) for 5 days. Food intake (FI) and body weight (BW) were measured daily. Gene expression in adipose tissue and bone marrow was assessed using RT–PCR. Leptin reduced FI (P < 0.05) and BW (P < 0.05), whereas ghrelin increased BW (P < 0.05) without affecting FI. Leptin decreased fat pad weights, whereas ghrelin (G330) increased fat pad weights (P < 0.05). In epididymal adipose tissue, leptin increased expression of lipolysis marker ADRB2 and thermogenesis marker MFN2 and decreased expression of adipogenic markers, FASN, SLC2A4, and SCD1, whereas ghrelin increased expression of FASN and SCD1. Leptin decreased bone marrow adipocyte size and number; however, ghrelin had no effect on these parameters. In whole bone marrow, leptin decreased expression of FASN and SCD1 and increased expression of DLK1, whereas ghrelin (G330) decreased expression of COL1A1. Thus, leptin induces similar changes in bone marrow and adipose tissue gene expression, reflecting the decreased adiposity in both compartments.
Similar content being viewed by others
Abbreviations
- ADRB2:
-
Adrenergic, beta-2 receptor
- ALPL:
-
Alkaline phosphatase
- ANXA5:
-
Annexin A5
- BBC3:
-
Bcl-2 binding component 3
- BGLAP:
-
Bone gamma-carboxy glutamate (gla) protein
- BGN:
-
Biglycan
- BMP2:
-
Bone morphogenetic protein 2
- CASP2:
-
Caspase 2
- CD36:
-
CD36 molecule (thrombospondin receptor)
- CEBPA:
-
CCAAT/enhancer binding protein (C/EBP), alpha
- COLIA1:
-
collagen type I alpha 1
- CTSK:
-
Cathepsin K
- DLK1:
-
Delta-like 1 homolog
- EGF:
-
Epidermal growth factor
- FABP4:
-
Fatty acid binding protein 4
- FASN:
-
Fatty acid synthase
- FGF14:
-
Fibroblast growth factor 14
- FN1:
-
Fibronectin 1
- GAPDH:
-
Glyceraldehyde-3-phosphate
- GATA-3:
-
GATA binding protein 3
- GPD1:
-
Glycerol-3-phosphate dehydrogenase 1
- LEP:
-
Leptin
- LEPR:
-
Leptin receptor
- LIPE:
-
Lipase, hormone-sensitive
- LPL:
-
Lipoprotein lipase
- SMAD1:
-
SMAD family member 1
- MFN 2:
-
Mitofusin 2
- MMP11:
-
Matrix metallopeptidase 11
- PPARα:
-
Peroxisome-proliferator-activated receptor alpha
- PPARγ:
-
Peroxisome-proliferator-activated receptor gamma
- RTN:
-
RTN hypothetical protein
- SCD1:
-
Stearoyl-CoA desaturase 1
- SERPINH1:
-
Serine (or cysteine) peptidase inhibitor, clade H member 1
- SLC2A4:
-
Solute carrier family 2 (facilitated glucose transporter), member 4
- SPARC:
-
Secreted protein, acidic cysteine-rich (osteonectin)
- SRA1:
-
Steroid receptor RNA activator 1
- TNF:
-
Tumor necrosis factor
- UCP1:
-
Uncoupling protein 1
- UCP3:
-
Uncoupling protein 2
- UCP3:
-
Uncoupling protein 3
- VEGF:
-
Vascular endothelial growth factor precursor
- EP:
-
Epididymal fat pad
- RP:
-
Retroperitoneal fat pad
- ING:
-
Inguinal fat pad
- GC:
-
Gastrocnemius muscle
References
Y.-H. Choi, C.L. Li, D. Hartzell, D.E. Little, M.A. Della-Fera, C.A. Baile, ICV leptin effects on spontaneous physical activity and feeding behavior in rats. Behav. Brain Res. 188, 100–108 (2008)
M.A. Della-Fera, H. Qian, C.A. Baile, Adipocyte apoptosis in the regulation of body fat mass by leptin. Diabetes Obes. Metab. 3, 299–310 (2001)
G. Fruhbeck, M. Aguado, J. Gomez-Ambrosi, J.A. Martinez, Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem. Biophys. Res. Commun. 250, 99–102 (1998)
P. Ducy, M. Amling, S. Takeda, M. Priemel, A.F. Schilling, F.T. Beil, J. Shen, C. Vinson, J.M. Rueger, G. Karsenty, Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197–207 (2000)
F. Elefteriou, S. Takeda, K. Ebihara, J. Magre, N. Patano, C.A. Kim, Y. Ogawa, X. Liu, S.M. Ware, W.J. Craigen, J.J. Robert, C. Vinson, K. Nakao, J. Capeau, G. Karsenty, Serum leptin level is a regulator of bone mass. Proc. Natl Acad. Sci. USA 101, 3258–3263 (2004)
T. Thomas, The complex effects of leptin on bone metabolism through multiple pathways. Curr. Opin. Pharmacol. 4, 295–300 (2004)
M.W. Hamrick, S.L. Ferrari, Leptin and the sympathetic connection of fat to bone. Osteoporos. Int. 19, 905–912 (2008)
W.R. Holloway, F.M. Collier, C.J. Aitken, D.E. Myers, J.M. Hodge, M. Malakellis, T.J. Gough, G.R. Collier, G.C. Nicholson, Leptin inhibits osteoclast generation. J. Bone Miner. Res. 17, 200–209 (2002)
J.O. Gordeladze, C.A. Drevon, U. Syversen, J.E. Reseland, Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J. Cell. Biochem. 85, 825–836 (2002)
T. Thomas, F. Gori, S. Khosla, M.D. Jensen, B. Burguera, B.L. Riggs, Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140, 1630–1638 (1999)
M.W. Hamrick, M.A. Della-Fera, Y.H. Choi, D. Hartzell, C. Pennington, C.A. Baile, Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow. Cell Tissue Res. 327, 133–141 (2007)
M.W. Hamrick, M.A. Della-Fera, Y.H. Choi, C. Pennington, D. Hartzell, C.A. Baile, Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J. Bone Miner. Res. 20, 994–1001 (2005)
M. Tschop, D.L. Smiley, M.L. Heiman, Ghrelin induces adiposity in rodents. Nature 407, 908–913 (2000)
C. Theander-Carrillo, P. Wiedmer, P. Cettour-Rose, R. Nogueiras, D. Perez-Tilve, P. Pfluger, T.R. Castaneda, P. Muzzin, A. Schurmann, I. Szanto, M.H. Tschop, F. Rohner-Jeanrenaud, Ghrelin action in the brain controls adipocyte metabolism. J. Clin. Invest. 116, 1983–1993 (2006)
N. Fukushima, R. Hanada, H. Teranishi, Y. Fukue, T. Tachibana, H. Ishikawa, S. Takeda, Y. Takeuchi, S. Fukumoto, K. Kangawa, K. Nagata, M. Kojima, Ghrelin directly regulates bone formation. J. Bone Miner. Res. 20, 790–798 (2005)
K. Matsumura, T. Tsuchihashi, K. Fujii, I. Abe, M. Iida, Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 40, 694–699 (2002)
N. Gallardo, E. Bonzon-Kulichenko, T. Fernandez-Agullo, E. Molto, S. Gomez-Alonso, P. Blanco, J.M. Carrascosa, M. Ros, A. Andres, Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology 148, 5604–5610 (2007)
W. Zhang, M.A. Della-Fera, D.L. Hartzell, D. Hausman, C.A. Baile, Adipose tissue gene expression profiles in ob/ob mice treated with leptin. Life Sci. 83, 35–42 (2008)
A.M. Wren, C.J. Small, C.R. Abbott, W.S. Dhillo, L.J. Seal, M.A. Cohen, R.L. Batterham, S. Taheri, S.A. Stanley, M.A. Ghatei, S.R. Bloom, Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540–2547 (2001)
R. Nogueiras, M.H. Tschop, J.M. Zigman, Central nervous system regulation of energy metabolism: ghrelin versus leptin. Ann. N. Y. Acad. Sci. 1126, 14–19 (2008)
M. Yukawa, D.S. Weigle, C.D. Davis, B.T. Marck, T. Wolden-Hanson, Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1453–R1460 (2008)
S. Strassburg, S.D. Anker, T.R. Castaneda, L. Burget, D. Perez-Tilve, P.T. Pfluger, R. Nogueiras, H. Halem, J.Z. Dong, M.D. Culler, R. Datta, M.H. Tschop, Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am. J. Physiol. Endocrinol. Metab. 295, E78–E84 (2008)
V. Cirmanova, M. Bayer, L. Starka, K. Zajickova, The effect of leptin on bone: an evolving concept of action. Physiol. Res. 57(Suppl 1), S143–S151 (2008)
C. Garces, M.J. Ruiz-Hidalgo, E. Bonvini, J. Goldstein, J. Laborda, Adipocyte differentiation is modulated by secreted delta-like (dlk) variants and requires the expression of membrane-associated dlk. Differentiation 64, 103–114 (1999)
B.M. Abdallah, P. Boissy, Q. Tan, J. Dahlgaard, G.A. Traustadottir, K. Kupisiewicz, J. Laborda, J.M. Delaisse, M. Kassem, dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J. Biol. Chem. 282, 7339–7351 (2007)
Y.H. Choi, C. Li, K. Page, A. Westby, M.A. Della-Fera, J. Lin, D.L. Hartzell, C.A. Baile, Melanocortin receptors mediate leptin effects on feeding and body weight but not adipose apoptosis. Physiol. Behav. 79, 795–801 (2003)
M. Shintani, Y. Ogawa, K. Ebihara, M. Aizawa-Abe, F. Miyanaga, K. Takaya, T. Hayashi, G. Inoue, K. Hosoda, M. Kojima, K. Kangawa, K. Nakao, Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50, 227–232 (2001)
Acknowledgment
This study was supported in part by Georgia Research Alliance Eminent Scholar endowment held by CAB.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ambati, S., Li, Q., Rayalam, S. et al. Central leptin versus ghrelin: effects on bone marrow adiposity and gene expression. Endocr 37, 115–123 (2010). https://doi.org/10.1007/s12020-009-9274-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-009-9274-z